Advancements in the molecular diagnostic testing of lung cancer have led to new treatments that can battle lung cancer, the most common cause of cancer death worldwide. To ensure that clinicians stay apace and provide optimal patient care, three leading medical societies, the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP), have updated their 2013 evidence-based guideline.
The "Updated ...
Advancements in the molecular diagnostic testing of lung cancer have led to new treatments that can battle lung cancer, the most common cause of cancer death worldwide. To ensure that clinicians stay apace and provide optimal patient care, three leading medical societies, the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP), have updated their 2013 evidence-based guideline.
The "Updated ...